Galectin-3, GDF-15, and sST2 for the Assessment of Disease Severity and Therapy Response in patients suffering from inoperable Chronic Thromboembolic Pulmonary Hypertension.
Conclusion: GDF-15 and sST2 levels are higher in CTEPH and identified patients with advanced hemodynamic impairment. Further, decreased GDF-15 levels at follow-up were associated with hemodynamic therapy response. The diagnostic strength was not superior to NT-proBNP.
PMID: 32901511 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research
More News: Angioplasty | Baloon Angioplasty | Cardiology | Cardiovascular | Heart | Hypertension | Pulmonary Hypertension | Research | Study